Gavin Dunn, MD, PhD
Gavin Dunn, MD, PhD
Director, Center for Brain Tumor Immunology and Immunotherapy
Boston, MAPhone: 617-726-4922
About Gavin Dunn, MD, PhD
Dr. Dunn is a board-certified neurosurgeon who specializes in neurosurgical oncology. At MGH, he is the Director of the Center for Brain Tumor Immunology and Immunotherapy. His practice centers on the management of patients with primary and metastatic brain cancers as well as general neurosurgical conditions. He has a comprehensive background employing technological adjuncts such as awake surgery, cortical mapping, laser ablation, fluorescence-guided surgery, and stereotactic radiosurgery. He is a fellow and member of the American Association of Neurological Surgeons (AANS), member of the Congress of Neurological Surgeons (CNS) and Society for Immunotherapy of Cancer (SITC), and member of the Board of Directors of the Society for Neuro-Oncology (SNO).
Born in London, Dr. Dunn grew up in central Missouri and graduated summa cum laude from Princeton University. He received his MD and PhD degrees in the Medical Scientist Training Program at the Washington University School of Medicine in St. Louis where his doctoral work in cancer immunology was performed with Dr. Robert Schreiber. He completed his neurosurgical training at the Massachusetts General Hospital, where he conducted postdoctoral research in functional cancer genomics with Dr. William Hahn at the Broad Institute and Dana-Farber Cancer Institute. Prior to joining MGH, Dr. Dunn was an Associate Professor of Neurological Surgery and a Bursky Scholar in the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs at Washington University where he was also the Director the Neurological Surgery Residency Training Program.
Dr. Dunn’s NIH-funded research program focuses on understanding the immune response to brain tumors and the fundamental basis of CNS immunobiology in order to improve the lives of patients with brain cancers. His work on the Brain Tumor Immunity cycle involves preclinical models as well as translational work and has resulted in the development of novel personalized cancer vaccine clinical studies. He is a co-chair of a clinical trial through the Alliance for Clinical Trials in Neuro-Oncology focused on recurrent glioblastoma.
Dr. Dunn is also a Commander in the United States Navy Reserves Medical Corps.
- Cortical mapping and awake surgery
- Fluorescence-guided Surgery
- Laser interstitial thermal therapy
- Metastatic Brain Tumor
- Stereotactic Radiosurgery
Mass General Surgery
55 Fruit St.
Boston, MA 02114
- MD, Washington University School of Medicine
- Residency, Massachusetts General Hospital*****
American Board Certifications
- Neurological Surgery, American Board of Neurological Surgery
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Mass General Brigham Health Plan - PBO
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Tufts Health Plan
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
#1 Research Hospital in America
Mass General is the #1 hospital in New England based on U.S. News & World Report Best Hospitals for 2022-2023.
Reviews: Comments and Ratings